Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
- 30 August 2002
- journal article
- clinical trial
- Published by Springer Nature in Leukemia
- Vol. 16 (9) , 1627-1636
- https://doi.org/10.1038/sj.leu.2402677
Abstract
Leukemia is one of the leading journals in hematology and oncology. It is published monthly and covers all aspects of the research and treatment of leukemia and allied diseases. Studies of normal hemopoiesis are covered because of their comparative relevance.Keywords
This publication has 37 references indexed in Scilit:
- How I treat older patients with AMLBlood, 2000
- Treatment of acute myelogenous leukemia in older adultsLeukemia, 2000
- A phase II trial of induction and consolidation therapy of acute myeloid leukemia with weekly oral idarubicin alone in poor risk elderly patientsLeukemia, 1999
- Acute Myeloid LeukemiaNew England Journal of Medicine, 1999
- Acute myeloid leukemia in the elderly: ‘per aspera ad astra’?Leukemia Research, 1999
- Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.Journal of Clinical Oncology, 1998
- The management of recurrent acute myelogenous leukaemia at a single centre over a fifteen‐year periodBritish Journal of Haematology, 1993
- Results of Therapy for Acute Myeloid Leukemia in First RelapseLeukemia & Lymphoma, 1991
- PRINCIPAL RESULTS OF THE MEDICAL RESEARCH COUNCIL'S 8th ACUTE MYELOID LEUKAEMIA TRIALThe Lancet, 1986
- Reinduction Chemotherapy for Acute Nonlymphocytic LeukemiaMayo Clinic Proceedings, 1984